Efficacy of Systemic Amoxicillin–Metronidazole in Periodontitis Patients with Diabetes Mellitus: A Systematic Review of Randomized Clinical Trials

Abstract

Background: Diabetes mellitus is a metabolic illness that is non-communicable, chronic, and associated with hyperglycemia. It is caused by a combination of the incapability of tissues that exhibit sensitivity to insulin in response to its release & defective secretion of insulin by β-cells of the pancreas.

Aim: To assesses efficiency of a combination of amoxicillin-metronidazole in enhancing periodontal variables in type 2 diabetes cases in comparison with standard periodontal treatment.

Materials and methods: This systematic review has been performed on four studies regarding the guidelines by the Cochrane Collaboration reporting followed the PRISMA statement (Preferred Reporting Items for Systematic Reviews and Meta-analyses).

Results: All four investigations demonstrated that systemic amoxicillin– metronidazole enhanced periodontal health when utilized in combination with nonsurgical periodontal treatments. Miranda et al. & El Makaky et al. illustrated significant decreases in probing depth (PD), bleeding on probing (BOP) & clinical attachment loss (CAL) at 3 months when systemic amoxicillin–metronidazole has been utilized in comparison to deferred management or scaling & root planning (SRP) alone.

Conclusion: This systematic review proposed that the combination of nonsurgical periodontal treatments with systemic amoxicillin–metronidazole may result in improved clinical results. Disparities have been noted in the antibiotic prescriptions' durations and dosages, as well as in the management's conducted to the control groups.